Статті в журналах з теми "Chemotherapy biomarker"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Chemotherapy biomarker".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Bukhari, Ali A., and Ranjit K. Goudar. "Thymidylate Synthase as a Predictive Biomarker for Pemetrexed Response in NSCLC." Lung Cancer International 2013 (December 25, 2013): 1–7. http://dx.doi.org/10.1155/2013/436409.
Повний текст джерелаCho, William CS, Timothy TC Yip, Roger KC Ngan, Tai-Tung Yip, Vladimir N. Podust, Christine Yip, Harry HY Yiu, et al. "ProteinChip Array Profiling for Identification of Disease- and Chemotherapy-Associated Biomarkers of Nasopharyngeal Carcinoma." Clinical Chemistry 53, no. 2 (February 1, 2007): 241–50. http://dx.doi.org/10.1373/clinchem.2005.065805.
Повний текст джерелаRuddy, Kathryn Jean, Anne M. O'Neill, Kathy Miller, Bryan P. Schneider, Emily Baker, Joseph A. Sparano, Chau T. Dang, Donald W. Northfelt, and George W. Sledge. "Biomarker prediction of chemotherapy-related amenorrhea." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 9508. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9508.
Повний текст джерелаChristensen, Ib Jarle, Gunilla Høyer-Hansen, Tine Thurison, Barry Dowell, Julia S. Johansen, Rikke Henriksen, Kristoffer Staal Rohrberg, Nils Brunner, and Hans J. Nielsen. "The prognostic value of seven soluble proteins measured in plasma or serum from patients with colorectal cancer in TNM stages I-III." Journal of Clinical Oncology 30, no. 30_suppl (October 20, 2012): 35. http://dx.doi.org/10.1200/jco.2012.30.30_suppl.35.
Повний текст джерелаMoik, Florian, Sabine Zöchbauer-Müller, Florian Posch, Ingrid Pabinger, and Cihan Ay. "Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer." Cancers 12, no. 6 (June 18, 2020): 1619. http://dx.doi.org/10.3390/cancers12061619.
Повний текст джерелаParks, R. M., L. H. Alfarsi, A. R. Green, and K. L. Cheung. "Biology of primary breast cancer in older women beyond routine biomarkers." Breast Cancer 28, no. 5 (June 24, 2021): 991–1001. http://dx.doi.org/10.1007/s12282-021-01266-5.
Повний текст джерелаAdashek, Jacob, Alexey Goloubev, Shumei Kato, and Razelle Kurzrock. "179 Immunotherapy trials lack a biomarker for inclusion: implications for drug development." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A192. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0179.
Повний текст джерелаChen, Yong-Zi, Youngchul Kim, Hatem H. Soliman, GuoGuang Ying, and Jae K. Lee. "Single drug biomarker prediction for ER− breast cancer outcome from chemotherapy." Endocrine-Related Cancer 25, no. 6 (June 2018): 595–605. http://dx.doi.org/10.1530/erc-17-0495.
Повний текст джерелаDemir, Muzaffer, A. Ciftci, Debra Hoppensteadt, G. Altiay, Mahemut Tobu, Omer Iqbal, Dan Fareed, Cafer Adiquzel, Michelle Kujawski, and Jawed Fareed. "ProteinChip Array Profiling and Markers of Inflammation and Thrombin Generation in Plasma Samples from Lung Cancer Patients and Their Modulation by Chemotherapy with or without Warfarin Anticoagulation." Blood 110, no. 11 (November 16, 2007): 3978. http://dx.doi.org/10.1182/blood.v110.11.3978.3978.
Повний текст джерелаCarcò, Daniela, Paolo Castorina, Paola Guardo, Valeria Iachelli, Tecla Pace, Paola Scirè, Rosaria Stanco, et al. "Combination of Interleukin-6, C-Reactive Protein and Procalcitonin Values as Predictive Index of Sepsis in Course of Fever Episode in Adult Haematological Patients: Observational and Statistical Study." Journal of Clinical Medicine 11, no. 22 (November 17, 2022): 6800. http://dx.doi.org/10.3390/jcm11226800.
Повний текст джерелаPennell, Nathan A., Maria E. Arcila, David R. Gandara, and Howard West. "Biomarker Testing for Patients With Advanced Non–Small Cell Lung Cancer: Real-World Issues and Tough Choices." American Society of Clinical Oncology Educational Book, no. 39 (May 2019): 531–42. http://dx.doi.org/10.1200/edbk_237863.
Повний текст джерелаPrattes, Juergen, Reinhard B. Raggam, Kim Vanstraelen, Jasmin Rabensteiner, Christoph Hoegenauer, Robert Krause, Florian Prüller, Albert Wölfler, Isabel Spriet, and Martin Hoenigl. "Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?" Journal of Clinical Microbiology 54, no. 3 (December 30, 2015): 798–801. http://dx.doi.org/10.1128/jcm.02972-15.
Повний текст джерелаAdemola, AdeyinkaF, ModupeA Kuti, and Adeyemi Ogunleye. "Cardiac biomarker changes with neoadjuvant epirubicin-based chemotherapy." Nigerian Journal of Cardiology 13, no. 2 (2016): 107. http://dx.doi.org/10.4103/0189-7969.187708.
Повний текст джерелаAubele, Michaela, Manfred Schmitt, Rudolf Napieralski, Stefan Paepke, Johannes Ettl, Magdalena Absmaier, Viktor Magdolen, et al. "The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges." Disease Markers 2017 (2017): 1–14. http://dx.doi.org/10.1155/2017/4934608.
Повний текст джерелаOloomi, Mana, Neda Moazzezy, and Saeid Bouzari. "Modulation of Molecular Biomarker Expression in Response to Chemotherapy in Invasive Ductal Carcinoma." BioMed Research International 2018 (2018): 1–8. http://dx.doi.org/10.1155/2018/7154708.
Повний текст джерелаWang, Jie, Yanhua Tian, Zhijie Wang, Hua Bai, and Jianchun Duan. "Prognostic prediction of pemetrexed-platinum chemotherapeutic regimen for NSCLC by serum metabolomics." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e20603-e20603. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e20603.
Повний текст джерелаMiura, John Thomas, Thejus T. Jayakrishnan, Daniel Eastwood, Fabian McCartney Johnston, Susan Tsai, Kathleen K. Christians, Kiran Turaga, and T. Clark Gamblin. "Molecular profiling in gastric cancer: Examining potential targets for chemotherapy." Journal of Clinical Oncology 32, no. 3_suppl (January 20, 2014): 131. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.131.
Повний текст джерелаKane, John M., Anthony Magliocco, Qiang Zhang, Dian Wang, Alex Klimowicz, Jonathan Harris, Jeff Simko, Thomas DeLaney, William Kraybill, and David G. Kirsch. "Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation." Sarcoma 2018 (2018): 1–10. http://dx.doi.org/10.1155/2018/8310950.
Повний текст джерелаBergsland, Christian H., Jarle Bruun, Marianne G. Guren, Aud Svindland, Merete Bjørnslett, Jørgen Smeby, Merete Hektoen, et al. "Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer." ESMO Open 5, no. 6 (November 2020): e001040. http://dx.doi.org/10.1136/esmoopen-2020-001040.
Повний текст джерелаTozuka, Takehiro, Rintaro Noro, Masahiro Seike, and Kazufumi Honda. "Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability." Cancers 14, no. 18 (September 7, 2022): 4363. http://dx.doi.org/10.3390/cancers14184363.
Повний текст джерелаPatel, Shruti Rajesh, Joerg Herrmann, Robert A. Vierkant, Janet E. Olson, Fergus J. Couch, Antonious Hazim, Jeff A. Sloan, Charles L. Loprinzi, and Kathryn J. Ruddy. "N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors." Journal of Clinical Medicine 10, no. 15 (July 27, 2021): 3313. http://dx.doi.org/10.3390/jcm10153313.
Повний текст джерелаYu, Irene S., Francine Aubin, Rachel Goodwin, Jonathan M. Loree, Cheryl Mather, Brandon S. Sheffield, Stephanie Snow, and Sharlene Gill. "Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline." Therapeutic Advances in Medical Oncology 14 (January 2022): 175883592211117. http://dx.doi.org/10.1177/17588359221111705.
Повний текст джерелаPádua, Diana, Débora Filipa Pinto, Paula Figueira, Carlos Filipe Pereira, Raquel Almeida, and Patrícia Mesquita. "HMGA1 Has Predictive Value in Response to Chemotherapy in Gastric Cancer." Current Oncology 29, no. 1 (December 23, 2021): 56–67. http://dx.doi.org/10.3390/curroncol29010005.
Повний текст джерелаWang, Zixuan, Kaiyuan Xing, Bo Zhang, Yanru Zhang, Tengyue Chai, Jingkai Geng, Xuexue Qin, Xinxin Zhang, and Chaohan Xu. "Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II–III Colorectal Cancer." International Journal of Molecular Sciences 23, no. 20 (October 18, 2022): 12460. http://dx.doi.org/10.3390/ijms232012460.
Повний текст джерелаKaplan, Richard, Timothy Maughan, Angela Crook, David Fisher, Richard Wilson, Louise Brown, and Mahesh Parmar. "Evaluating Many Treatments and Biomarkers in Oncology: A New Design." Journal of Clinical Oncology 31, no. 36 (December 20, 2013): 4562–68. http://dx.doi.org/10.1200/jco.2013.50.7905.
Повний текст джерелаWalsh, Christine S., Seishi Ogawa, Hisae Karahashi, Daniel R. Scoles, James C. Pavelka, Hang Tran, Carl W. Miller, et al. "ERCC5 Is a Novel Biomarker of Ovarian Cancer Prognosis." Journal of Clinical Oncology 26, no. 18 (June 20, 2008): 2952–58. http://dx.doi.org/10.1200/jco.2007.13.5806.
Повний текст джерелаKopetz, Scott. "“Right Drug for the Right Patient”: Hurdles and the Path Forward in Colorectal Cancer." American Society of Clinical Oncology Educational Book, no. 33 (May 2013): e115-e120. http://dx.doi.org/10.14694/edbook_am.2013.33.e115.
Повний текст джерелаNikas, Jason B., Walter C. Low, and Paul A. Burgio. "Prognosis of Treatment Response (Pathological Complete Response) in Breast Cancer." Biomarker Insights 7 (January 2012): BMI.S9387. http://dx.doi.org/10.4137/bmi.s9387.
Повний текст джерелаEvran, Ebru, Hilal Şahin, Kübra Akbaş, Sadik Çiğdem, and Esra Gündüz. "Investigation of MACC1 Gene Expression in Head and Neck Cancer and Cancer Stem Cells." Clinical & Investigative Medicine 39, no. 6 (December 1, 2016): 77. http://dx.doi.org/10.25011/cim.v39i6.27506.
Повний текст джерелаZhu, Feng, Jing Ma, Dongdong Ru, Ningning Wu, Yunhua Zhang, Huiyuan Li, Xiaoli Liu, et al. "Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy." Journal of Oncology 2021 (May 26, 2021): 1–10. http://dx.doi.org/10.1155/2021/5569783.
Повний текст джерелаHaykal, Maria M., Sylvie Rodrigues-Ferreira, and Clara Nahmias. "Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer." Cells 10, no. 5 (May 1, 2021): 1080. http://dx.doi.org/10.3390/cells10051080.
Повний текст джерелаYarden, Ronit, and Tamara Springer. "Precision medicine in colorectal cancer: Gaps in patients’ literacy of biomarkers and genetic testing." Journal of Clinical Oncology 38, no. 4_suppl (February 1, 2020): 55. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.55.
Повний текст джерелаChaft, Jamie E., Yu Shyr, Boris Sepesi, and Patrick M. Forde. "Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer." Journal of Clinical Oncology 40, no. 6 (February 20, 2022): 546–55. http://dx.doi.org/10.1200/jco.21.01589.
Повний текст джерелаMa, Zhiyao, Marissa Williams, Yuen Yee Cheng, and Wai K. Leung. "Roles of Methylated DNA Biomarkers in Patients with Colorectal Cancer." Disease Markers 2019 (March 3, 2019): 1–8. http://dx.doi.org/10.1155/2019/2673543.
Повний текст джерелаPotenza, Enrico, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, and Paolo Zola. "Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer." International Journal of Biological Markers 35, no. 4 (October 30, 2020): 20–27. http://dx.doi.org/10.1177/1724600820955195.
Повний текст джерелаNishioka, Yujiro, Junichi Shindoh, Yoshinori Inagaki, Wataru Gonoi, Jun Mitsui, Hiroyuki Abe, Ryuji Yoshioka, et al. "Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases." Digestive Diseases 36, no. 6 (2018): 437–45. http://dx.doi.org/10.1159/000490411.
Повний текст джерелаBoys, Rachel. "P06 Improving renal function monitoring during chemotherapy- a role for cystatin C?" Archives of Disease in Childhood 105, no. 9 (August 19, 2020): e8.2-e9. http://dx.doi.org/10.1136/archdischild-2020-nppg.15.
Повний текст джерелаWeber, Wolfgang A. "Positron Emission Tomography As an Imaging Biomarker." Journal of Clinical Oncology 24, no. 20 (July 10, 2006): 3282–92. http://dx.doi.org/10.1200/jco.2006.06.6068.
Повний текст джерелаShenasa, Elahe, Elisabeth Specht Stovgaard, Maj-Britt Jensen, Karama Asleh, Nazia Riaz, Dongxia Gao, Samuel Leung, Bent Ejlertsen, Anne-Vibeke Laenkholm, and Torsten O. Nielsen. "Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial." Cancers 14, no. 15 (August 5, 2022): 3808. http://dx.doi.org/10.3390/cancers14153808.
Повний текст джерелаGyorffy, Balazs. "Abstract P4-07-20: Survival analysis using the entire transcriptome to pinpoint biomarkers with the highest prognostic power." Cancer Research 82, no. 4_Supplement (February 15, 2022): P4–07–20—P4–07–20. http://dx.doi.org/10.1158/1538-7445.sabcs21-p4-07-20.
Повний текст джерелаChen, Yuxiao, Rui Zhu, Min Chen, Wenna Guo, Xin Yang, Xin-Jian Xu, and Liucun Zhu. "Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma." Journal of Oncology 2020 (May 15, 2020): 1–11. http://dx.doi.org/10.1155/2020/8106212.
Повний текст джерелаTsao, Anne S., Nusrat Harun, Junya Fujimoto, Vikki Devito, J. Jack Lee, Reza J. Mehran, Waun Ki Hong, Milind B. Suraokar, and Ignacio I. Wistuba. "Elevated PDGFRB gene copy number gain as prognostic in resected malignant pleural mesothelioma." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 7078. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.7078.
Повний текст джерелаSasatomi, Teruo, Yutaka Ogata, Hideaki Yamana, Yoshito Akagi, and Kazuo Shirouzu. "Immunological effects as a biomarker of chemotherapy in metastatic colorectal cancer." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e14077-e14077. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e14077.
Повний текст джерелаJongeneel, Gabrielle, Marjolein J. E. Greuter, Felice N. van Erning, Miriam Koopman, Geraldine R. Vink, Cornelis J. A. Punt, and Veerle M. H. Coupé. "Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients." Therapeutic Advances in Gastroenterology 14 (January 2021): 175628482199571. http://dx.doi.org/10.1177/1756284821995715.
Повний текст джерелаFong, Caroline YK, and Ian Chau. "Harnessing biomarkers of response to improve therapy selection in esophago-gastric adenocarcinoma." Pharmacogenomics 22, no. 11 (July 2021): 703–26. http://dx.doi.org/10.2217/pgs-2020-0090.
Повний текст джерелаGoggi, Julian L., Shivashankar Khanapur, Siddesh V. Hartimath, Boominathan Ramasamy, Peter Cheng, Hui-Xian Chin, Jun-Rong Tang, You-Yi Hwang, and Edward G. Robins. "Imaging Effector Memory T-Cells Predicts Response to PD1-Chemotherapy Combinations in Colon Cancer." Biomedicines 10, no. 10 (September 20, 2022): 2343. http://dx.doi.org/10.3390/biomedicines10102343.
Повний текст джерелаHynninen, Johanna, Annika Auranen, Kirsti Dean, Maija Lavonius, Olli Carpen, Antti Perheentupa, Marko Seppänen, and Seija Grénman. "Serum HE4 Profile During Primary Chemotherapy of Epithelial Ovarian Cancer." International Journal of Gynecologic Cancer 21, no. 9 (November 2011): 1573–78. http://dx.doi.org/10.1097/igc.0b013e3182225509.
Повний текст джерелаWang, Yi-Zarn, Jean P. Carrasquillo, Alexis Carimi, Elizabeth McCord, Maria M. Chester, Robert Ramirez, J. Philip Boudreaux, Eugene Woltering, Daniel Raines, and Lowell Brian Anthony. "In vitro chemotherapy profiling of well-differentiated midgut neuroendocrine tumors (NETs) based on individual patient tumor biomarkers analysis." Journal of Clinical Oncology 32, no. 3_suppl (January 20, 2014): 235. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.235.
Повний текст джерелаGarcia-Carbonero, Nuria, Javier Martinez-Useros, Weiyao Li, Alberto Orta, Nuria Perez, Cristina Carames, Tatiana Hernandez, Irene Moreno, Gloria Serrano, and Jesus Garcia-Foncillas. "KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study." Cells 9, no. 1 (January 15, 2020): 219. http://dx.doi.org/10.3390/cells9010219.
Повний текст джерелаMehta, Anurag, Nayana N. Sriramanakoppa, Poojan Agarwal, Gayatri Viswakarma, Smreti Vasudevan, Manoj Panigrahi, Dushyant Kumar, et al. "Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association." South Asian Journal of Cancer 08, no. 04 (October 2019): 250–54. http://dx.doi.org/10.4103/sajc.sajc_373_18.
Повний текст джерела